CRP and type 2 diabetes mellitus: Elevated plasma levels of systemic inflammatory biomarkers such as C-reactive protein (CRP) and fibrinogen have been shown to predict CVD(3), stroke, type 2 diabetes mellitus, cancer and dementia(4,5).